-
1
-
-
77954770305
-
-
World Health Organization, Geneva: WHO
-
World Health Organization. Tuberculosis facts 200. Geneva: WHO; 2007.
-
(2007)
Tuberculosis Facts 200
-
-
-
2
-
-
0030917745
-
Noncompliance with directly observed therapy for tuberculosis: Epidemiology and effect on the outcome of treatment
-
Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis: epidemiology and effect on the outcome of treatment. Chest. 1997;111:1168-73.
-
(1997)
Chest
, vol.111
, pp. 1168-1173
-
-
Burman, W.J.1
Cohn, D.L.2
Rietmeijer, C.A.3
Judson, F.N.4
Sbarbaro, J.A.5
Reves, R.R.6
-
3
-
-
0036345152
-
New polymeric carriers for controlled drug delivery following inhalation or injection
-
Fu J, Fiegel J, Krauland E, Hanes J. New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials. 2002;23:4425-33.
-
(2002)
Biomaterials
, vol.23
, pp. 4425-4433
-
-
Fu, J.1
Fiegel, J.2
Krauland, E.3
Hanes, J.4
-
4
-
-
1242286956
-
Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs
-
Prabakaran D, Singh P, Jaganathan KS, Vyas SP. Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs. J Control Release. 2004;95:239-48.
-
(2004)
J. Control Release
, vol.95
, pp. 239-248
-
-
Prabakaran, D.1
Singh, P.2
Jaganathan, K.S.3
Vyas, S.P.4
-
5
-
-
0035834186
-
Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation
-
Shishoo CJ, Shah SA, Rathod IS, Savale SS, Vora MJ. Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation. Int J Pharm. 2001;228:53-67.
-
(2001)
Int. J. Pharm.
, vol.228
, pp. 53-67
-
-
Shishoo, C.J.1
Shah, S.A.2
Rathod, I.S.3
Savale, S.S.4
Vora, M.J.5
-
6
-
-
0035834176
-
A critical review of the probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem
-
Singh S, Mariappan TT, Shankar R, Sarda N, Singh B. A critical review of the probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem. Int J Pharm. 2001;228:5-17.
-
(2001)
Int. J. Pharm.
, vol.228
, pp. 5-17
-
-
Singh, S.1
Mariappan, T.T.2
Shankar, R.3
Sarda, N.4
Singh, B.5
-
7
-
-
0034776041
-
Liposomes and PLG microparticles as sustained release antitubercular drug carriers-an in vitro-in vivo study
-
Dutt M, Khuller GK. Liposomes and PLG microparticles as sustained release antitubercular drug carriers-an in vitro-in vivo study. Int J Antimicrob Agents. 2001;18:245-52.
-
(2001)
Int. J. Antimicrob. Agents
, vol.18
, pp. 245-252
-
-
Dutt, M.1
Khuller, G.K.2
-
8
-
-
0033795452
-
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Manufacture and characterization
-
O'Hara P, Hickey AJ. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization. Pharm Res. 2000;17:955-61.
-
(2000)
Pharm. Res.
, vol.17
, pp. 955-961
-
-
O'Hara, P.1
Hickey, A.J.2
-
9
-
-
0035190045
-
Studies on rifampicin release from ethylcellulose coated nonpareil beads
-
Rao BS, Murthy K V R. Studies on rifampicin release from ethylcellulose coated nonpareil beads. Int J Pharm. 2002;231:97-106.
-
(2002)
Int. J. Pharm.
, vol.231
, pp. 97-106
-
-
Rao, B.S.1
Murthy, K.V.R.2
-
10
-
-
0034812708
-
Airways delivery of rifampicin microparticles for the treatment of tuberculosis
-
Suarez S, O'Hara P, Kazantseva M, Newcomer CE, Hopfer R, McMurray DN et al. Airways delivery of rifampicin microparticles for the treatment of tuberculosis. J Antimicrob Chemother. 2001;48:431-4.
-
(2001)
J. Antimicrob. Chemother.
, vol.48
, pp. 431-434
-
-
Suarez, S.1
O'Hara, P.2
Kazantseva, M.3
Newcomer, C.E.4
Hopfer, R.5
McMurray, D.N.6
-
11
-
-
0347418154
-
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages
-
Vyas SP, Kannan ME, Jain S, Mishra V, Singh P. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm. 2004;269:37-49.
-
(2004)
Int. J. Pharm.
, vol.269
, pp. 37-49
-
-
Vyas, S.P.1
Kannan, M.E.2
Jain, S.3
Mishra, V.4
Singh, P.5
-
12
-
-
33750051651
-
Characterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionate
-
Gaber NN, Darwis Y, Peh KK, Tan Y T F. Characterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionate. J Nanosci Nanotechnol. 2006;6:1-7.
-
(2006)
J. Nanosci. Nanotechnol.
, vol.6
, pp. 1-7
-
-
Gaber, N.N.1
Darwis, Y.2
Peh, K.K.3
Tan, Y.T.F.4
-
13
-
-
0031962780
-
Polymer-coated long-circulating microparticulate pharmaceuticals
-
Torchilin VP. Polymer-coated long-circulating microparticulate pharmaceuticals. J Microencapsul. 1998;15:1-19.
-
(1998)
J. Microencapsul
, vol.15
, pp. 1-19
-
-
Torchilin, V.P.1
-
14
-
-
0028043631
-
Long circulating, cationic liposomes containing amino-PEG- phosphatidylethanolamine
-
Zalipsky S. Long circulating, cationic liposomes containing amino-PEG-phosphatidylethanolamine. FEBS Lett. 1994;353:71-4.
-
(1994)
FEBS Lett.
, vol.353
, pp. 71-74
-
-
Zalipsky, S.1
-
16
-
-
0032778659
-
Polymeric micelles-a new generation of colloidal drug carriers
-
Jones MC, Leroux JC. Polymeric micelles-a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 1999;48:101-11.
-
(1999)
Eur. J. Pharm. Biopharm.
, vol.48
, pp. 101-111
-
-
Jones, M.C.1
Leroux, J.C.2
-
17
-
-
0141921484
-
Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery
-
Lukyanov AN, Gao Z, Torchilin VP. Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery. J Control Release. 2003;91:97-102.
-
(2003)
J. Control Release
, vol.91
, pp. 97-102
-
-
Lukyanov, A.N.1
Gao, Z.2
Torchilin, V.P.3
-
18
-
-
11844282711
-
Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions
-
Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release. 2005;102:373-81.
-
(2005)
J. Control Release
, vol.102
, pp. 373-381
-
-
Yamamoto, H.1
Kuno, Y.2
Sugimoto, S.3
Takeuchi, H.4
Kawashima, Y.5
-
19
-
-
42649137232
-
Targeted delivery of nanoparticles for the treatment of lung diseases
-
Azarmi S, Roa WH, Lolbenberg R. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev. 2008;60:863-75.
-
(2008)
Adv. Drug Deliv. Rev.
, vol.60
, pp. 863-875
-
-
Azarmi, S.1
Roa, W.H.2
Lolbenberg, R.3
-
20
-
-
0033931658
-
Drug properties affecting aerosol behavior
-
Suarez S, Hickey AJ. Drug properties affecting aerosol behavior. Respir Care. 2000;45:652-66.
-
(2000)
Respir. Care
, vol.45
, pp. 652-666
-
-
Suarez, S.1
Hickey, A.J.2
-
21
-
-
0035979417
-
Dry powder inhalation of liposomal Ketotifen fumarate: Formulation and characterization
-
Joshi M, Misra A. Dry powder inhalation of liposomal Ketotifen fumarate: Formulation and characterization. Int J Pharma. 2001;223:15-27.
-
(2001)
Int. J. Pharma
, vol.223
, pp. 15-27
-
-
Joshi, M.1
Misra, A.2
-
23
-
-
0025836446
-
The development of a mathematical approximation technique to determine the mass median aerodynamic diameter (MMAD) and geometric standard deviation (GSD) of drug particles in an inhalation aerosol spray
-
Wiggins NA. The development of a mathematical approximation technique to determine the mass median aerodynamic diameter (MMAD) and geometric standard deviation (GSD) of drug particles in an inhalation aerosol spray. Drug Dev Ind Pharm. 1991;17:1971-86.
-
(1991)
Drug Dev. Ind. Pharm.
, vol.17
, pp. 1971-1986
-
-
Wiggins, N.A.1
-
24
-
-
0037409984
-
Preparation and drug release behaviors of nimodipine-loaded poly (caprolactone)-poly (ethylene oxide)-polylactide amphiphilic copolymer nanoparticles
-
Hu Y, Jiang X, Ding Y, Zhang L, Yang C, Zhang J et al. Preparation and drug release behaviors of nimodipine-loaded poly (caprolactone)-poly (ethylene oxide)-polylactide amphiphilic copolymer nanoparticles. Biomaterials. 2003;24:2395-404.
-
(2003)
Biomaterials
, vol.24
, pp. 2395-2404
-
-
Hu, Y.1
Jiang, X.2
Ding, Y.3
Zhang, L.4
Yang, C.5
Zhang, J.6
-
25
-
-
33846565915
-
Nanoparticles-a historical perspective
-
Kreuter J. Nanoparticles-a historical perspective. Int J Pharm. 2007;331:1-10.
-
(2007)
Int. J. Pharm.
, vol.331
, pp. 1-10
-
-
Kreuter, J.1
-
26
-
-
0037353238
-
Thermodynamic characteristics of DSPC/DSPE-PEG2000 mixed monolayers on the water subphase at different temperatures
-
Chou TH, Chu IM. Thermodynamic characteristics of DSPC/DSPE-PEG2000 mixed monolayers on the water subphase at different temperatures. Colloids Surf B: Biointerfaces. 2003;27:333-44.
-
(2003)
Colloids Surf B: Biointerfaces
, vol.27
, pp. 333-344
-
-
Chou, T.H.1
Chu, I.M.2
-
27
-
-
0029980834
-
Development of amphiphilic diblock copolymers as micellar carriers of taxol
-
Zhang X, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm. 1996;132:195-206.
-
(1996)
Int. J. Pharm.
, vol.132
, pp. 195-206
-
-
Zhang, X.1
Jackson, J.K.2
Burt, H.M.3
-
28
-
-
0035857723
-
Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes
-
Darwis Y, Kellaway IW. Nebulisation of rehydrated freeze-dried beclomethasone dipropionate liposomes. Int J Pharm. 2001;215:113-21.
-
(2001)
Int. J. Pharm.
, vol.215
, pp. 113-121
-
-
Darwis, Y.1
Kellaway, I.W.2
-
29
-
-
2142728539
-
Solid-state characterization of rifampicin samples and its biopharmaceutic relevance
-
Agrawal S, Ashokraj Y, Bharatam PV, Pillai O, Panchagnula R. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci. 2004;22:127-44.
-
(2004)
Eur. J. Pharm. Sci.
, vol.22
, pp. 127-144
-
-
Agrawal, S.1
Ashokraj, Y.2
Bharatam, P.V.3
Pillai, O.4
Panchagnula, R.5
-
30
-
-
33947183154
-
Alginate microspheres of isoniazid for oral sustained drug delivery
-
Rastogi R, Sultana Y, Aqil M, Ali A, Kumar S, Chuttani K et al. Alginate microspheres of isoniazid for oral sustained drug delivery. Int J Pharm. 2007;334:71-7.
-
(2007)
Int. J. Pharm.
, vol.334
, pp. 71-77
-
-
Rastogi, R.1
Sultana, Y.2
Aqil, M.3
Ali, A.4
Kumar, S.5
Chuttani, K.6
-
31
-
-
0032559233
-
Methoxy poly (ethylene glycol) and ∈-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formulation and drug release behaviours
-
Kim SY, Shin I L G, Lee YM, Cho CS, Sung YK. Methoxy poly (ethylene glycol) and ∈-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formulation and drug release behaviours. J Control Release. 1998;51:13-22.
-
(1998)
J. Control Release
, vol.51
, pp. 13-22
-
-
Kim, S.Y.1
Shin, I.L.G.2
Lee, Y.M.3
Cho, C.S.4
Sung, Y.K.5
-
32
-
-
0037148656
-
Poly (ethylene oxide)-blockpoly (L-amino acid) micelles for drug delivery
-
Lavasanifar A, Samuel J, Kwon GS. Poly (ethylene oxide)-blockpoly (L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev. 2002;54:169-90.
-
(2002)
Adv. Drug Deliv. Rev.
, vol.54
, pp. 169-190
-
-
Lavasanifar, A.1
Samuel, J.2
Kwon, G.S.3
-
33
-
-
22544471541
-
Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone
-
Zhang Y, Zhuo RX. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone. Biomaterials. 2005;26:6736-42.
-
(2005)
Biomaterials
, vol.26
, pp. 6736-6742
-
-
Zhang, Y.1
Zhuo, R.X.2
|